Loading clinical trials...
Loading clinical trials...
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States in subjects with atopic dermatitis.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vanda Pharmaceuticals
NCT07223697 · Atopic Dermatitis
NCT07298395 · Atopic Dermatitis (AD)
NCT07217015 · Atopic Dermatitis
NCT06116526 · Atopic Dermatitis
NCT07006792 · Atopic Dermatitis
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Tempe, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions